Phase I dose-escalation and pharmacokinetic (PK) study of a(6-maleimidocaproyl)hydrazone derivative of doxorubicin (DOXO-EMCH) in patients with advanced cancers No significant financial relationships ...
Single-Agent Versus Combination Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The Cancer and Leukemia Group B (study 9730) Malignant pleural mesothelioma (MPM) carries a poor prognosis due to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results